ViewRay (VRAY) Stock Forecast, Price & News

ViewRay (NASDAQ:VRAY) Frequently Asked Questions

Is ViewRay a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ViewRay in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ViewRay stock.
View analyst ratings for ViewRay or view top-rated stocks.

When is ViewRay's next earnings date?

ViewRay is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for ViewRay.

How were ViewRay's earnings last quarter?

ViewRay, Inc. (NASDAQ:VRAY) issued its earnings results on Thursday, May, 5th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.16) by $0.02. The business had revenue of $18.88 million for the quarter, compared to the consensus estimate of $15.62 million. ViewRay had a negative net margin of 148.47% and a negative trailing twelve-month return on equity of 76.00%. The company's quarterly revenue was up 21.6% compared to the same quarter last year. During the same quarter last year, the company posted ($0.17) EPS.
View ViewRay's earnings history.

What guidance has ViewRay issued on next quarter's earnings?

ViewRay updated its FY 2022 earnings guidance on Monday, May, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $84.00 million-$104.00 million, compared to the consensus revenue estimate of $94.73 million.

What price target have analysts set for VRAY?

4 Wall Street analysts have issued 1-year target prices for ViewRay's stock. Their forecasts range from $7.00 to $7.00. On average, they expect ViewRay's share price to reach $7.00 in the next year. This suggests a possible upside of 132.6% from the stock's current price.
View analysts' price targets for ViewRay or view top-rated stocks among Wall Street analysts.

Who are ViewRay's key executives?

ViewRay's management team includes the following people:

• Mr. Scott William Drake, Pres, CEO & Director (Age 54, Pay $1.41M) (LinkedIn Profile)
• Mr. Zachary William Stassen, Chief Financial Officer (Age 43, Pay $413.08k) (LinkedIn Profile)
• Dr. James F. Dempsey, Chief Scientific Officer (Age 51, Pay $523.09k)
• Ms. Ashley Kluth, Sr. Mang. of Investor Relations
• Mr. Robert S. McCormack, Sr. VP, Gen. Counsel & Corp. Sec.
• Karen Hackstaff, VP of Marketing
• Mr. Robert Michael Fuchs, Chief HR Officer (Age 55)
• Dr. Martin Fuss, Chief Medical Officer
• Mr. Paul Ziegler Jr., Chief Commercial Officer
• Ms. Amanda Sequira, Sr. VP of Clinical, Quality & Regulatory (Age 44)

What is Scott Drake's approval rating as ViewRay's CEO?

5 employees have rated ViewRay CEO Scott Drake on Glassdoor.com. Scott Drake has an approval rating of 59% among ViewRay's employees. This puts Scott Drake in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of ViewRay's key competitors?

Some companies that are related to ViewRay include Natus Medical (NTUS), Outset Medical (OM), Cutera (CUTR), TransMedics Group (TMDX), BioLife Solutions (BLFS), AxoGen (AXGN), Zynex (ZYXI), Edap Tms (EDAP), Hyperfine (HYPR), Semler Scientific (SMLR), Stereotaxis (STXS), FONAR (FONR), Electromed (ELMD), Electromed (ELMD) and Second Sight Medical Products (EYES).
View all of VRAY's competitors.

What other stocks do shareholders of ViewRay own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ViewRay investors own include Alibaba Group (BABA), Amarin (AMRN), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Verastem (VSTM), Corbus Pharmaceuticals (CRBP), Viking Therapeutics (VKTX), AbbVie (ABBV), Accuray (ARAY) and Selecta Biosciences (SELB).

When did ViewRay IPO?

(VRAY) raised $52 million in an initial public offering (IPO) on the week of April 6th 2015. The company issued 4,000,000 shares at $12.00-$14.00 per share. Cowen and Company and Stifel acted as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

What is ViewRay's stock symbol?

ViewRay trades on the NASDAQ under the ticker symbol "VRAY."

Who are ViewRay's major shareholders?

ViewRay's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (5.71%), Vanguard Group Inc. (4.91%), State Street Corp (2.41%), Neuberger Berman Group LLC (2.30%), Candriam Luxembourg S.C.A. (0.96%) and Dimensional Fund Advisors LP (0.86%). Company insiders that own ViewRay stock include Brian K Roberts, Caley Castelein, Influence Ltd Strong, International Ltd Fosun, Scott William Drake, Susan C Schnabel and Zachary William Stassen.
View institutional ownership trends for ViewRay.

Which institutional investors are selling ViewRay stock?

VRAY stock was sold by a variety of institutional investors in the last quarter, including Tamarack Advisers LP, Calamos Advisors LLC, Sei Investments Co., Russell Investments Group Ltd., Dimensional Fund Advisors LP, Candriam Luxembourg S.C.A., UBS Group AG, and Peregrine Capital Management LLC. Company insiders that have sold ViewRay company stock in the last year include Influence Ltd Strong, and International Ltd Fosun.
View insider buying and selling activity for ViewRay or view top insider-selling stocks.

Which institutional investors are buying ViewRay stock?

VRAY stock was purchased by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, JPMorgan Chase & Co., Vanguard Group Inc., Renaissance Technologies LLC, Engineers Gate Manager LP, BlackRock Inc., Kahn Brothers Group Inc., and GSA Capital Partners LLP. Company insiders that have bought ViewRay stock in the last two years include Brian K Roberts, Caley Castelein, Scott William Drake, Susan C Schnabel, and Zachary William Stassen.
View insider buying and selling activity for ViewRay or or view top insider-buying stocks.

How do I buy shares of ViewRay?

Shares of VRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ViewRay's stock price today?

One share of VRAY stock can currently be purchased for approximately $3.01.

How much money does ViewRay make?

ViewRay has a market capitalization of $543.18 million and generates $70.12 million in revenue each year. The company earns $-110.05 million in net income (profit) each year or ($0.64) on an earnings per share basis.

How many employees does ViewRay have?

ViewRay employs 267 workers across the globe.

What is ViewRay's official website?

The official website for ViewRay is www.viewray.com.

How can I contact ViewRay?

ViewRay's mailing address is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. The company can be reached via phone at (440) 703-3210, via email at [email protected], or via fax at 800-417-3459.